The NIH Consensus Development Conference on Adjuvant Chemotherapy for Breast Cancer — a commentary Marc E. Lippman Commentary Pages: 195 - 200
Progestin therapy for breast cancer William L McGuireFranco CavalliJ Alexieva-Figusch Viewpoints Pages: 213 - 220
Assessment of malignancy potential in so-called interval mammary carcinomas Anette von RosenKerstin ErhardtGert Auer Report Pages: 221 - 227
Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay C. Kent OsborneDaniel D. Von HoffKathryn Mullins Report Pages: 229 - 235
Regulation of breast tumor growth by high dose estrogen is independent of the presence of estrogen receptors Verena HugBenjamin DrewinkoGeorge Blumenschein Report Pages: 237 - 240
Cyclic nucleotide levels in human breast cancer and in rat mammary tissues during tumor development Ella IsraeliBatya RazDavid Barzilai Report Pages: 241 - 248
Tumor markers and their significance in the management of breast cancer Roberto CerianiElizabeth P. Anderson Meeting Report Pages: 249 - 254
Growth promoting influences of estradiol, epidermal growth factor, and insulin on human breast cancer: Evidence for differential mechanism of action on tumor cells in vitro Stefano IacobelliClara Natoli Correspondence Pages: 255 - 256